mode of action of semaglutide Mechanism for management obesity, NASH, and Semaglutide: Double-edged Sword with Risks
Description
Is higher-dose semaglutide more dangerous or cause more side effects
They fail it when the reason is cosmetic weight loss with no diagnosis
Wegovy is covered for the cardiovascular indication (CVD plus overweight or obesity) following the CMS coverage update in March 2024, not for weight loss alone
Managing Side Effects Side effect management significantly impacts treatment success
What to monitor: The same factors as the 1 mg phase, plus blood glucose patterns if you monitor them, hydration status (GLP-1 agonists can reduce thirst cues), and mood or energy shifts that may indicate metabolic transition
Until they weigh in I cant be mad if someone is doing something I recognize this approach isnt perfect, just think it is least bad jiffylush December 14, 2023, 11:33am 45 I get that its a relatively novel drug to most people but why am I not seeing more talk about this bit
